202 related articles for article (PubMed ID: 23493191)
1. Targeted therapies of solid cancers: new options, new challenges.
Awada A; Aftimos PG
Curr Opin Oncol; 2013 May; 25(3):296-304. PubMed ID: 23493191
[TBL] [Abstract][Full Text] [Related]
2. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
3. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
Ludwig WD
Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
[TBL] [Abstract][Full Text] [Related]
4. Individualized targeted therapy for glioblastoma: fact or fiction?
Weller M; Stupp R; Hegi M; Wick W
Cancer J; 2012; 18(1):40-4. PubMed ID: 22290256
[TBL] [Abstract][Full Text] [Related]
5. MR evaluation of response to targeted treatment in cancer cells.
Podo F; Canevari S; Canese R; Pisanu ME; Ricci A; Iorio E
NMR Biomed; 2011 Jul; 24(6):648-72. PubMed ID: 21387442
[TBL] [Abstract][Full Text] [Related]
6. Somatic alterations as the basis for resistance to targeted therapies.
Blair BG; Bardelli A; Park BH
J Pathol; 2014 Jan; 232(2):244-54. PubMed ID: 24114654
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care.
Bex A; Gore M; Mulders P; Sternberg CN
BJU Int; 2012 Nov; 110(9):1289-300. PubMed ID: 22624610
[TBL] [Abstract][Full Text] [Related]
8. Genomics, personalized medicine and cancer practice.
Dancey J
Clin Biochem; 2012 Apr; 45(6):379-81. PubMed ID: 22424082
[No Abstract] [Full Text] [Related]
9. Personalized oncology: genomic screening in phase 1.
Tuxen IV; Jønson L; Santoni-Rugiu E; Hasselby JP; Nielsen FC; Lassen U
APMIS; 2014 Aug; 122(8):723-33. PubMed ID: 25046202
[TBL] [Abstract][Full Text] [Related]
10. Molecularly targeted cancer therapy: some lessons from the past decade.
Huang M; Shen A; Ding J; Geng M
Trends Pharmacol Sci; 2014 Jan; 35(1):41-50. PubMed ID: 24361003
[TBL] [Abstract][Full Text] [Related]
11. Impact of tumor sequencing on the use of anticancer drugs.
Thomas F; Desmedt C; Aftimos P; Awada A
Curr Opin Oncol; 2014 May; 26(3):347-56. PubMed ID: 24709974
[TBL] [Abstract][Full Text] [Related]
12. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
Parkinson DR; Johnson BE; Sledge GW
Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
[TBL] [Abstract][Full Text] [Related]
13. [Response predictive biomarkers to targeted therapies in oncology].
Harlé A; Merlin JL
Ann Biol Clin (Paris); 2013 Nov; 71():89-97. PubMed ID: 24235332
[TBL] [Abstract][Full Text] [Related]
14. Applications of systems biology in cancer immunotherapy: from target discovery to biomarkers of clinical outcome.
Guhathakurta D; Sheikh NA; Meagher TC; Letarte S; Trager JB
Expert Rev Clin Pharmacol; 2013 Jul; 6(4):387-401. PubMed ID: 23927667
[TBL] [Abstract][Full Text] [Related]
15. Biomarker-driven patient selection for early clinical trials.
Dienstmann R; Rodon J; Tabernero J
Curr Opin Oncol; 2013 May; 25(3):305-12. PubMed ID: 23493192
[TBL] [Abstract][Full Text] [Related]
16. Predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert M; Hummel M; Bläker H; Müller BM; Lehmann A; Denkert C; Heppner FL; Koch A; Sers C; Anagnostopoulos I
Cancer Gene Ther; 2013 Apr; 20(4):211-21. PubMed ID: 23492822
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer management: opportunities and barriers to an individualized approach.
Perez EA
Oncologist; 2011; 16 Suppl 1():20-2. PubMed ID: 21278437
[TBL] [Abstract][Full Text] [Related]
18. Impact of genomics on personalized cancer medicine.
Arteaga CL; Baselga J
Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
[TBL] [Abstract][Full Text] [Related]
19. Translating genomic discoveries to the clinic in pediatric oncology.
Glade Bender J; Verma A; Schiffman JD
Curr Opin Pediatr; 2015 Feb; 27(1):34-43. PubMed ID: 25502895
[TBL] [Abstract][Full Text] [Related]
20. Genomic medicine frontier in human solid tumors: prospects and challenges.
Dienstmann R; Rodon J; Barretina J; Tabernero J
J Clin Oncol; 2013 May; 31(15):1874-84. PubMed ID: 23589551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
